← SynDRA
BISOPROLOL
SynDRA canonical compound SYN0001293 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ADRB1 |
| Mechanism of action | Adrenergic receptor antagonist |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-1 Receptor Antagonists
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympatholytics
ATC classes
- C07A · BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
- BETA BLOCKING AGENTS, OTHER COMBINATIONS
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- bisoprolol hemifumarate
- bisoprolol fumarate
- CL 297,939
- EMD-33-512
- Bisocor
- Bisoprololum
- Cardicor
- Concor
- Detensiel
- Emconcor
- Emcor
- Euradal
- Isoten
- Monocor
- Soloc
- Soprol
- Zebeta
- Bisoprolol fumerate
- Bisoprolol hemifumarate
- Bisoprololum [Latin]
- CL-297939
- Concor (TN)
- Concore (TN)
- EMD-33512
- Monocor (TN)
- Zebeta (TN)
- Bisoprolol (USAN/INN)
- Bisoprolol [USAN:BAN:INN]
- (+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
- (RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
- 1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
- 1-[(1-methylethyl)amino]-3-({4-[({2-[(1-methylethyl)oxy]ethyl}oxy)methyl]phenyl}oxy)propan-2-ol
- 1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol
- Y41JS2NL6U
- CHEBI:3127
- Bisoprololum (Latin)
- bisoprololo
- RefChem:5608
Reported adverse events
- Bradycardia
- Rash
- Fatigue
- Asthma
- Dizziness
- Dry mouth
- Purpura
- Arthralgia
- Orthostatic hypotension
- Vertigo
- Erythema multiforme
- Stevens-Johnson syndrome
Look up BISOPROLOL in the interactive SynDRA portal →